MetLife, Inc.

MET

Financial ServicesInsurance - LifeNYSE

$69.86

Market Cap: $46.00B

MetLife, Inc. (MET) Valuation Summary

DCF FAIR VALUE

$382.96

Market Price

$69.86

Upside / Downside

+448.2%

Verdict

Undervalued

Using a 5-year unlevered FCFF model with Gordon Growth terminal value, MetLife, Inc. (MET) has an intrinsic value of $382.96 (range: $248.50 – $989.66), suggesting the stock is undervalued by 448.2% relative to its current market price of $69.86.

Model	Range	Fair Value	Upside
▸ Discounted Cash Flow
Growth Exit 5Y	$248.50 – $989.66	$382.96	+448.6%
Growth Exit 10Y	$292.36 – $1,136.12	$446.94	+540.2%
EBITDA Exit 5Y	$216.61 – $483.57	$338.72	+385.2%
EBITDA Exit 10Y	$253.96 – $557.99	$382.91	+448.5%
▸ Trading Multiples
P/E	$47.27 – $80.29	$66.27	-5.1%
EV/EBITDA	$75.01 – $92.94	$90.11	+29.1%
▸ PEG
PEG Fair Value	$244.59 – $244.59	$244.59	+250.4%
▸ Earnings Power Value
Earnings Power Value	$227.56 – $345.86	$274.39	+293.0%

How we calculated this: The fair value is derived from a 5-year unlevered FCFF model with line-by-line expense modeling, discounted at the WACC (7.2%). The terminal value uses a Gordon Growth perpetual rate based on MetLife, Inc.'s classification as a CyclicalCyclicalEarnings fluctuate significantly with economic cycles.· Low growth (~5% CAGR)· Thin margins (4.4% net margin)· Strong dividend yield (3.3%)· Highly cyclical earnings· Strong FCF yield (39.4%) company. Other models are shown below for reference.

Valuation History

Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions. Data sourced from SEC filings via Financial Modeling Prep. Last updated: 3/28/2026.